Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.

BACKGROUND The natural history of parathyroid function after successful renal transplantation (RT) and the factors predisposing to persistent hyperparathyroidism (HPT) are not well established. A better knowledge of these data may be helpful in the development of algorithms for optimal surveillance and treatment of HPT after successful RT. Our aim was to evaluate the post-transplant natural history of parathyroid function and calcium metabolism in patients with a functional renal graft and to identify risk factors for persistent HPT. METHODS Charts of 1165 allograft kidney recipients transplanted between 1989 and 2000 were reviewed. Patients with an intact parathyroid hormone (iPTH) level available at the time of transplantation were identified. The charts of the latter patients were checked for a variety of demographic and clinical data, and all determinations of the iPTH concentration available since transplantation were recorded. Serum levels of calcium, phosphorus, alkaline phosphatases and creatinine, concurrently determined, were also registered. RESULTS After an initial fall, iPTH levels showed a slow but steady decline towards the upper normal limit. The prevalence of persistent HPT, defined as an iPTH level > or =2.5 times the upper normal limit or the need for parathyroidectomy following transplantation, remained stable at approximately 17% up to 4 years after transplantation. Patients with persistent HPT had significantly elevated serum levels of iPTH, calcium and phosphorus at the time of RT, and had spent a longer time on dialysis. Post-transplant iPTH levels correlated significantly with transplant kidney function. CONCLUSION Kidney transplant recipients with a high iPTH and calcium x phosphate product at the time of transplantation are at risk for persistent HPT especially when renal function is suboptimal. Therapy for persistent HPT, if considered, should be initiated 3 months post-transplantation since further spontaneous improvement of parathyroid function thereafter is limited.

[1]  M. Levi,et al.  Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia. , 2001, Kidney international.

[2]  G. Choukroun,et al.  Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis. , 2001, The Journal of clinical endocrinology and metabolism.

[3]  M. Aparicio,et al.  Reduced parathyroid functional mass after successful kidney transplantation. , 1999, Kidney international.

[4]  P. Jehle,et al.  Long-Term Results of Total Parathyroidectomy without Autotransplantation in Patients with and without Renal Failure , 1999, Mineral and Electrolyte Metabolism.

[5]  P. Messa,et al.  Persistent secondary hyperparathyroidism after renal transplantation. , 1998, Kidney international.

[6]  T. Drüeke.  Primary and secondary uraemic hyperparathyroidism: from initial clinical observations to recent findings. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  U. Heemann,et al.  Sequential changes of biochemical bone parameters after kidney transplantation. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  F. Caravaca,et al.  Are plasma 1,25-dihydroxyvitamin D3 concentrations appropriate after successful kidney transplantation? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  A. Torres,et al.  Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  K. O̸lgaard,et al.  PTH--one can teach an old hormone new tricks. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  C. Bresson,et al.  No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  L. Rostaing,et al.  Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. , 1997, Clinical nephrology.

[13]  J. Nordenström,et al.  Bone demineralization after renal transplantation: contribution of secondary hyperparathyroidism manifested by hypercalcaemia. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  R. Bouillon,et al.  Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. , 1990, Clinical chemistry.

[15]  M. Kleerekoper,et al.  Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure. , 1986, Mineral and electrolyte metabolism.

[16]  Parfitt Am.  Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. , 1982 .

[17]  K. Hruska,et al.  Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone. , 1981, Kidney international.

[18]  M. Kaye,et al.  Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention. , 1979, Kidney international.